First company in the world to offer preclinical drug tests for children with cancer

ITCC-P4 gGmbH is the world’s first company offering preclinical drug tests exclusively for children with cancer. Founded by the Hopp Children’s Cancer Centre in Heidelberg (KiTZ) and DKFZ, along with 15 academic partners, three biotech companies, and ten pharmaceutical companies, ITCC-P4 is dedicated to advancing pediatric cancer research. Congratulations to all the founding partners for their dedication and contributions to this important cause.

Source: Kitz-heidelberg.de